Back to Search
SUNDHAR RAMALINGAM, M.D.
M.D.
Medical Oncology Physician
NPI: 1366768632IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
2014-02023(NC)
Education
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL SCHOOL OF MEDICINE
Class of 2010
Research & Publications (20)
Phase II study of belinostat (PXD101), a histone deacetylase inhibitor, for second line therapy of advanced malignant pleural mesothelioma.
PMID 19096314·J Thorac Oncol·2009
3-trial
The role of the taxanes in the treatment of older patients with advanced stage non-small cell lung cancer.
PMID 19342473·Oncologist·2009
6-review
Novel intestinal splice variants of RNA-binding protein CUGBP2: isoform-specific effects on mitotic catastrophe.
PMID 18258790·Am J Physiol Gastrointest Liver Physiol·2008
7-preclinical
Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599.
PMID 18165641·J Clin Oncol·2008
2-rct
Dual inhibition of the epidermal growth factor receptor with cetuximab, an IgG1 monoclonal antibody, and gefitinib, a tyrosine kinase inhibitor, in patients with refractory non-small cell lung cancer (NSCLC): a phase I study.
PMID 18317068·J Thorac Oncol·2008
3-trial
A phase I study of 17-allylamino-17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignancies.
PMID 18519777·Clin Cancer Res·2008
3-trial
Comparison of outcomes for elderly patients treated with weekly paclitaxel in combination with carboplatin versus the standard 3-weekly paclitaxel and carboplatin for advanced nonsmall cell lung cancer.
PMID 18512224·Cancer·2008
3-trial
Recent advances in the treatment of malignant pleural mesothelioma.
PMID 18758312·J Thorac Oncol·2008
6-review
Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions.
PMID 18263769·Oncologist·2008
6-review
Role of bevacizumab for the treatment of non-small-cell lung cancer.
PMID 17381412·Future Oncol·2007
6-review
Phase I and pharmacokinetic study of vorinostat, a histone deacetylase inhibitor, in combination with carboplatin and paclitaxel for advanced solid malignancies.
PMID 17510206·Clin Cancer Res·2007
3-trial
Quantitative assessment of the p53-Mdm2 feedback loop using protein lysate microarrays.
PMID 17616682·Cancer Res·2007
8-other
Transmission of hepatitis B virus (genotype E) in a haemodialysis unit.
PMID 17826313·J Clin Virol·2007
8-other
Recent advances in targeted therapy for non-small cell lung cancer.
PMID 17227238·Expert Opin Ther Targets·2007
6-review
Treatment of elderly non-small cell lung cancer patients with three different schedules of weekly paclitaxel in combination with carboplatin: subanalysis of a randomized trial.
PMID 17409863·J Thorac Oncol·2006
3-trial
Salvage therapy for advanced non-small cell lung cancer: factors influencing treatment selection.
PMID 16794244·Oncologist·2006
6-review
Molecularly-targeted therapies for non-small cell lung cancer.
PMID 16316305·Expert Opin Pharmacother·2005
6-review
First-line chemotherapy for advanced-stage non-small-cell lung cancer: focus on docetaxel.
PMID 16384540·Clin Lung Cancer·2005
6-review
Phase I study of weekly (day 1 and 8) docetaxel in combination with capecitabine in patients with advanced solid malignancies.
PMID 15723261·Cancer Chemother Pharmacol·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2301 ERWIN RD
DURHAM, NC 27705 - Phone
- (919) 244-7237
Quick Facts
- NPI
- 1366768632
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile